ENHERTU plus pertuzumab supplemental New Drug Application submitted in Japan as first-line therapy for patients...

Adcendo ApS announces FDA Fast Track Designation granted to ADCE-D01 for the treatment of soft...

FDA greenlights PrimeLink Bio’s clinical trial of PLB-002

DATROWAY demonstrated statistically significant and clinically meaningful improvement in overall survival as first-line therapy for...

Lisata Therapeutics and Catalent announce global antibody-drug conjugate (ADC) license agreement

Turbine launches collaboration with AstraZeneca, leveraging Turbine’s virtual disease models to rationalize ADC discovery